Vanguard Global Advisers »

Trisalus Life Sciences shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $61k 15k 4.00

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Trisalus Life Sciences

First Light Asset Management
AWM Investment Company
Nantahala Capital Management
Vanguard Group
BlackRock
Daniel D. Thurber
Vanguard Capital Management
Gilder, Gagnon, Howe & Co
HPM Partners
Geode Capital Management
Thompson, Siegel, & Walmsley
Kennedy Capital Management
Morgan Stanley
Empire Financial Management Company
State Street Corporation

View all funds holding Trisalus Life Sciences